Novel Contraceptive Nextstellis Gets FDA Approval
Nextstellis is a novel combined oral contraceptive pill containing drospirenone 3mg (DRSP) and estetrol 14.2mg.
Obstetrics and Gynecology
Study Explores Oxytocin Use in Active Phase of Induced Labor
Discontinuation of oxytocin may lead to small increase in rate of cesarean section, decrease in fetal heart rate abnormalities
Even Moderate Caffeine Intake in Pregnancy Tied to Smaller Babies
Consuming more than 50 mg of caffeine per day (the amount in about half a cup of coffee) linked to lower birth weight
MPR Weekly Dose Podcast 75
The latest status on the Janssen vaccine; Updated guidance from the National Institutes of Health on COVID-19 antibody treatment; The FDA changes in-person mifepristone dispensing; A prefilled-syringe for Xolair injection is approved; And the AI world comes to colonoscopies.
FDA Lifts In-Person Dispensing Requirement for Mifepristone During Pandemic
Mifepristone is a progestin antagonist indicated, in a regimen with misoprostol, for the medical termination of intrauterine pregnancy through 70 days gestation.
Tisotumab Vedotin Under Review for Recurrent or Metastatic Cervical Cancer
Tisotumab vedotin is an investigational antibody-drug conjugate targeted to tissue factor.
COVID-19 Vaccination During Pregnancy May Protect Infant
The observed IgG transfer ratio demonstrates an infant antibody level about equal to maternal level
Stethoscope Remains Best Way to Monitor Fetal Distress During Labor
Review of 33 studies, including seven monitoring methods, shows no benefit from newer strategies
Pregnant Women Show Robust Immune Response to COVID-19 Vaccine
And passage of antibodies through the placenta and breastmilk appears to confer immunity to newborns
FDA Clears Point-of-Care Test for Chlamydia, Gonorrhea
The io instrument processes a single-use cartridge that contains all reagents for testing collected vaginal swabs and male urine samples.
